Evaluating the Clinical Significance of Diazepam Binding Inhibitor in Alzheimer's Disease: A Comparison with Inflammatory, Oxidative, and Neurodegenerative Biomarkers.

Gokce, Mustafa; Velioglu, Halil Aziz; Bektay, Muhammed Yunus; Guler, Eray Metin

Gokce, Mustafa; Velioglu, Halil Aziz; Bektay, Muhammed Yunus; Guler, Eray Metin.

Afiliación

Gokce M; Department of Pharmacology, Bezmialem Vakif University School of Pharmacy, Istanbul, Turkey.
Velioglu HA; Department of Pharmacology, Institute of Health Sciences, Istanbul University, Istanbul, Turkey.
Bektay MY; Center for Psychiatric Neuroscience, Feinstein Institute for Medical Research, Manhasset, New York, USA.
Guler EM; Functional Imaging and Cognitive-Affective Neuroscience Lab (fINCAN), Health Sciences and Technology Research Institute (SABITA), Regenerative and Restorative Medicine Research Center (REMER), Istanbul Medipol University, Istanbul, Turkey.

Gerontology ; 69(9): 1104-1112, 2023.

Article en En | MEDLINE | ID: mdl-37607528

Asunto(s)

Enfermedad de Alzheimer; Relevancia Clínica; Humanos; Enfermedad de Alzheimer/diagnóstico; Enfermedad de Alzheimer/tratamiento farmacológico; Inhibidor de la Unión a Diazepam; Biomarcadores; Estrés Oxidativo

Palabras clave

Ageing; Alzheimer's disease; Biomarker; Diazepam binding inhibitor; Inflammation; Oxidative stress

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer / Relevancia Clínica Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Gerontology Año: 2023 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google